Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment Receipt
Jeong Eun Min(Centre for Advancing Health Outcomes), Bohdan Nosyk(Simon Fraser University), Corey Ranger(Island Health), Brittany Barker(Simon Fraser University), Bernie Pauly, Amanda Slaunwhite(University of British Columbia), Karen Urbanoski(University of Victoria), Heather Palis(University of British Columbia), Ruyu Yan(Centre for Advancing Health Outcomes), Paxton Bach(University of British Columbia), Ashley Heaslip(University of British Columbia), Brenda Carolina Guerra‐Alejos(Centre for Advancing Health Outcomes)
Cited by 14
Related Papers
Characterization of Environmental Sources of the Human and Animal Pathogen <i>Cryptococcus gattii</i> in British Columbia, Canada, and the Pacific Northwest of the United States
|Applied and Environmental Microbiology|2006|238
Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
|Journal of General Internal Medicine|2019|150
Expansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol
|The Journal of Immunology|2009|148
<i>Cryptococcus gattii</i>Dispersal Mechanisms, British Columbia, Canada
|Emerging infectious diseases|2007|146
Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study
|Drug and Alcohol Dependence|2020|119